{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:24:53Z","timestamp":1793049893473,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.bcp.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T04:33:56Z","timestamp":1270874036000},"page":"297-307","source":"Crossref","is-referenced-by-count":70,"title":["Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)"],"prefix":"10.1016","volume":"80","author":[{"given":"Edward M.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.002_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ncpendmet0388","article-title":"Clinical lessons from the calcium-sensing receptor","volume":"3","author":"Brown","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","article-title":"Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs","volume":"270","author":"Garrett","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/138945007779315614","article-title":"Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors","volume":"8","author":"Brauner-Osborne","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2010.04.002_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1582-4934.2007.00096.x","article-title":"Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators","volume":"11","author":"Hu","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bcp.2010.04.002_bib7","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M701096200","article-title":"Identification and dissection of Ca2+-binding sites in the extracellular domain of Ca2+-sensing receptor","author":"Huang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1074\/jbc.M307191200","article-title":"Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site","volume":"279","author":"Miedlich","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"18990","DOI":"10.1074\/jbc.M400724200","article-title":"Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain","volume":"279","author":"Petrel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MNH.0b013e328332e7b2","article-title":"Novel Ca receptor signaling pathways for control of renal ion transport","volume":"19","author":"Huang","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.bcp.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ceca.2003.10.013","article-title":"Calcium sensing receptors as integrators of multiple metabolic signals","volume":"35","author":"Breitwieser","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2010.04.002_bib12","series-title":"Williams Textbook of Endocrinology","first-page":"1155","article-title":"Hormones and disorders of mineral metabolism","author":"Bringhurst","year":"1998"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2010.04.002_bib13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1744-9987.2007.00513.x","article-title":"Novel regulators of phosphate homeostasis and bone metabolism","volume":"11","author":"Juppner","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.bcp.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","article-title":"Osteoclast-osteoblast communication","volume":"473","author":"Matsuo","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2010.04.002_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00003.2004","article-title":"Calcium absorption across epithelia","volume":"85","author":"Hoenderop","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2010.04.002_bib16","doi-asserted-by":"crossref","first-page":"F795","DOI":"10.1152\/ajprenal.90625.2008","article-title":"Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD","volume":"296","author":"Nechama","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2010.04.002_bib17","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","article-title":"The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands","volume":"292","author":"Rodriguez","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2010.04.002_bib18","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D","volume":"277","author":"Canaff","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib19","doi-asserted-by":"crossref","first-page":"F1192","DOI":"10.1152\/ajprenal.00360.2009","article-title":"Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology","volume":"297","author":"Meir","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2010.04.002_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/138920109787847538","article-title":"The role of the calcium-sensing receptor in bone biology and pathophysiology","volume":"10","author":"Theman","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.bcp.2010.04.002_bib21","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1073\/pnas.0306141101","article-title":"Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones","volume":"101","author":"Dvorak","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.002_bib22","first-page":"S79","article-title":"Conditional knockouts in early and mature osteoblasts reveals a critical role for Ca2+ receptors in bone development","volume":"22","author":"Chang","year":"2007","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.bcp.2010.04.002_bib23","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1096\/fj.06-6304fje","article-title":"The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis","volume":"20","author":"Mentaverri","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2010.04.002_bib24","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.bmcl.2004.03.056","article-title":"N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor","volume":"14","author":"Kessler","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.04.002_bib25","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.002_bib26","doi-asserted-by":"crossref","first-page":"46622","DOI":"10.1074\/jbc.M207100200","article-title":"Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator","volume":"277","author":"Hu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.04.002_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncpendmet0394","article-title":"Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease","volume":"3","author":"Brown","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","article-title":"Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism","volume":"57","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000046658","article-title":"22-Oxacalcitriol upregulates p21(WAF1\/Cip1) in human parathyroid glands. A preliminary report","volume":"21","author":"Shiraishi","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats [In Process Citation]","volume":"11","author":"Chin","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2007.07.177","article-title":"Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells","volume":"362","author":"Mizobuchi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.04.002_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats [see comments]","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","article-title":"Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors","volume":"14","author":"Ogata","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib36","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/ki.2008.546","article-title":"Effects of calcimimetics on extraskeletal calcifications in chronic kidney disease","author":"Rodriguez","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.bcp.2010.04.002_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2008.10.043","article-title":"The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE\u2212\/\u2212) mice","volume":"205","author":"Ivanovski","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2010.04.002_bib38","doi-asserted-by":"crossref","first-page":"F1376","DOI":"10.1152\/ajprenal.90737.2008","article-title":"The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats","volume":"296","author":"Lopez","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2010.04.002_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2215\/CJN.04520908","article-title":"Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and\/or vitamin D derivatives","volume":"4","author":"Drueke","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2010.04.002_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib44","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.002_bib45","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib46","article-title":"Middle-term use of Cinacalcet in paediatric dialysis patientsm","author":"Platt","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib47","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/ndt\/gfm177","article-title":"Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies","volume":"22","author":"Drueke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2010.04.002_bib48","first-page":"537","article-title":"The genetic background of uremic secondary hyperparathyroidism","volume":"18","author":"Aucella","year":"2005","journal-title":"J Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib49","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","article-title":"Secondary and tertiary hyperparathyroidism, state of the art surgical management","volume":"89","author":"Pitt","year":"2009","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.bcp.2010.04.002_bib50","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/gfm156","article-title":"Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy","volume":"22","author":"Lomonte","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2010.04.002_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bcp.2010.04.002_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","article-title":"Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism","volume":"86","author":"Bergua","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2010.04.002_bib53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bcp.2010.04.002_bib54","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.transproceed.2009.06.090","article-title":"Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation","volume":"41","author":"Gomez Marques","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bcp.2010.04.002_bib55","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2009.06.055","article-title":"Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism","volume":"41","author":"Lopez","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bcp.2010.04.002_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e318186b7fb","article-title":"Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"86","author":"Borchhardt","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2010.04.002_bib57","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","article-title":"Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism","volume":"22","author":"Kruse","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2010.04.002_bib58","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.transproceed.2009.06.088","article-title":"Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism","volume":"41","author":"Toro Prieto","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bcp.2010.04.002_bib59","doi-asserted-by":"crossref","unstructured":"Jadoul M, Banos A, Zani VJ, Hercz G. The effects of discontinuing cinacalcet at the time of kidney transplantation, NDT Plus 3:37\u201341.","DOI":"10.1093\/ndtplus\/sfp167"},{"key":"10.1016\/j.bcp.2010.04.002_bib60","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib62","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib63","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib65","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2010.04.002_bib66","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s00268-009-9942-4","article-title":"Lithium therapy and hyperparathyroidism: an evidence-based assessment","volume":"33","author":"Saunders","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.bcp.2010.04.002_bib67","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.ki.5002065","article-title":"Lithium hypercalcemia, hyperparathyroidism, and cinacalcet","volume":"71","author":"Gregoor","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib68","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/j.ajkd.2006.07.019","article-title":"Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride","volume":"48","author":"Sloand","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bcp.2010.04.002_bib69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1590\/S0100-879X2001000500004","article-title":"Extracellular calcium-sensing receptor: structural and functional features and association with diseases","volume":"34","author":"Hauache","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bcp.2010.04.002_bib70","doi-asserted-by":"crossref","first-page":"33736","DOI":"10.1074\/jbc.M200978200","article-title":"L-phenylalanine and NPS R-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.04.002_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2796.2006.01684.x","article-title":"Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor","volume":"260","author":"Timmers","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.bcp.2010.04.002_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198202043060502","article-title":"An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds","volume":"306","author":"Marx","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.002_bib73","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2010.04.002_bib74","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bcp.2010.04.002_bib75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1525-139X.2007.00263.x","article-title":"Calcific uremic arteriolopathy: advances in pathogenesis and treatment","volume":"20","author":"Rogers","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.bcp.2010.04.002_bib76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2340\/00015555-0325","article-title":"Cinacalcet as first-line treatment for calciphylaxis","volume":"88","author":"Pallure","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.bcp.2010.04.002_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ki.2008.490","article-title":"A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia","volume":"75","author":"Koleganova","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.04.002_bib78","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e32832f0d22","article-title":"Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat","author":"Maillard","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.bcp.2010.04.002_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature04247","article-title":"Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor","volume":"439","author":"Adams","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.002_bib80","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1073\/pnas.0602996103","article-title":"Calcium-sensing receptor abrogates secretagogue- induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction","volume":"103","author":"Geibel","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.002_bib81","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1681\/ASN.2008090927","article-title":"Calcimimetic inhibits late-stage cyst growth in ADPKD","volume":"20","author":"Gattone","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210002479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210002479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T15:22:38Z","timestamp":1635175358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210002479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0006295210002479"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.04.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}